MRK vs CAH
By Alex · Tickerpine
Merck & Company, Inc. vs Cardinal Health, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | CAH |
|---|---|---|
| Price | $132.92 | $234.16 |
| Market cap | $327.94B | $54.46B |
| P/E ratio | 106.3 | 33.2 |
| ROE | 6.96% | — |
| Profit margin | 4.77% | 0.67% |
| Revenue growth | 5.10% | 5.80% |
| Dividend yield | 2.56% | 0.86% |
| Beta | 0.21 | — |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs CAH in plain English
- MRK is the bigger company — about 6.0× the market cap of CAH.
- CAH is cheaper on earnings (P/E 33.2 vs 106.3).
- CAH is growing revenue faster (6% vs 5%).
- MRK has the higher dividend yield (2.56% vs 0.86%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Company, Inc. would be worth today.
CAH return calculator
See what $1,000 in Cardinal Health, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.